Randomized Phase 3 study of Eryaspase in combination with either Gemcitibine/ Abraxane or FOLFIRI compared with Gemcitibine/ Abraxane or FOLFIRI alone as second line therapy in patients with stage III/IV pancreatic cancer

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Randomized Phase 3 study of Eryaspase in combination with either Gemcitibine/ Abraxane or FOLFIRI compared with Gemcitibine/ Abraxane or FOLFIRI alone as second line therapy in patients with stage III/IV pancreatic cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.